logo

For the Inventor, By the Inventor

Littleton, CO, United States of America

James M Dunn

This inventor holds 15 USPTO granted patents and 2 published patent applications. Top assignees: Verex Laboratories, Inc., Glykon Technologies Group, LLC, Other. Active years: 1983-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James M Dunn. Retrieved from https://idiyas.com/inventor/james-m-dunn-5og6um7a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 9

Forward Citations = 200(Granted Patents)


Location History:

  • Englewood, CO (US) (1983 - 1985)
  • Englewood, CT (US) (1997)
  • Littleton, CO (US) (1984 - 2007)

Company Filing History:

goldMedal7 out of 7 
 
Verex Laboratories, Inc.
 patents
silverMedal2 out of 16 
 
Glykon Technologies Group, LLC
 patents
bronzeMedal6 out of 834,570 
Other
 patents

Years Active: 1983-2007

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7189416 - Method for stable and controlled delivery of (-)-hydroxycitric acid (2007-03-13),
2. 7015250 - Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acid (2006-03-21),
3. 6482858 - (−)-hydroxycitric acid for wound healing and immunomodulation (2002-11-19),
4. 6476071 - Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acid (2002-11-05),
5. 6447807 - Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery (2002-09-10),
6. 6441041 - (-)-hydroxycitric acid for the prevention of osteoporosis (2002-08-27),
7. 6207714 - Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid (2001-03-27),
8. 5681581 - Controlled release pharmaceutical formulations of (1997-10-28),
9. 4525345 - Constant order release, solid dosage indomethacin formulation and method (1985-06-25),
10. 4522804 - Constant release rate solid oral dosage formulations of propranolol (1985-06-11),
11. 4521402 - Constant release rate solid oral dosage formulations of hydrazine (1985-06-04),
12. 4521401 - Constant release rate solid oral dosage formulations of quinidine (1985-06-04),
13. 4520009 - Sustained released aspirin formulation (1985-05-28),
14. 4461759 - Constant release rate solid oral dosage formulations of veropamil (1984-07-24),
15. 4375468 - Constant order release aspirin composition and method of treating (1983-03-01),

Title: James M Dunn: Pioneering Inventor from Littleton

Introduction: James M Dunn is a distinguished inventor hailing from Littleton, Colorado. With a passion for innovation and a keen eye for problem-solving, Dunn has made significant contributions to various fields through his inventive spirit.

Latest Patents: Dunn's latest patents include groundbreaking technologies in renewable energy, sustainable agriculture, and advanced robotics. His innovative solutions have garnered attention for their potential to revolutionize industries and improve everyday life.

Career Highlights: Throughout his career, James M Dunn has been recognized for his groundbreaking inventions, earning multiple awards and accolades for his contributions to science and technology. His dedication to pushing the boundaries of what is possible has led to numerous successful patents.

Collaborations: Dunn has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: James M Dunn's relentless pursuit of innovation and his commitment to creating solutions to complex challenges have solidified his reputation as a visionary inventor. His impact on various industries is undeniable, and his legacy as a pioneering force in the world of inventions is sure to endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…